Pfizer Inc. (PFE) Q1 2023 Earnings Results

Pfizer Beats on EPS, Stock Down 0.38%

Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.38%. This may reflect investor concerns about broader market conditions and the lack of revenue details or guidance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.23	N/A	+23.62%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed cautious optimism about future prospects despite current market challenges. They emphasized the importance of R&D in driving growth.

Management highlighted the importance of ongoing research and development.

They noted the challenges in the current market environment.

Focus remains on delivering value through innovation.

Pfizer Beats on EPS, Stock Down 0.38%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 0.38%

Key numbers

Management commentary